Featured Publications

CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancer 

Yan Y, Narayan A, Mazinani M, Saeki H, Huang T, Lofland G, Gabrielson E, Cope L, Kanaan YM, Afsari A, Naab T, Sukumar S, Pomper MG, Merino VF, 2026 Dec 28 Breast Cancer Research

Fluorine-18-labeled PET radiotracers for imaging the macrophage colony-stimulating factor 1 receptor (CSF1R) 

Das D, Cha H, Naik R, Holt DP, Fan H, Hall A, Lesniak WG, Du Y, Minn I, Dannals RF, Pomper MG, Horti AG, 2026 Dec 11 EJNMMI Radiopharmacy and Chemistry

PET-based risk stratification for adverse events under [225Ac]Ac-PSMA radioligand therapy 

Widjaja L, Siegmund SC, Gildehaus FJ, Schmidt-Hegemann NS, Pomper MG, Rowe SP, Bundschuh RA, Wenter V, Sheikh GT, Klimek K, Stief CG, Zacherl MJ, Werner RA, Casuscelli J, 2026 Jun European Journal of Nuclear Medicine and Molecular Imaging 53 4360-4373

Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma 

Novruzov E, Mamlins E, Widjaja L, Siegmund SC, Watabe T, Mori Y, Stief C, Tufman A, Herrmann K, Gorin MA, Pomper MG, Rowe SP, Giesel FL, Werner RA, Sheikh GT, 2026 May Journal of Nuclear Medicine 67 687-692

Stability of the translocator protein 18 kDa density within cognitive circuits in brains of virally-suppressed people with HIV 

Rubin LH, Maki PM, Du Y, Dastgheyb RM, Nam H, Rowe SP, Lesniak WG, Minn I, Hall AW, Mathews WB, Kassiou M, Dannals RF, Kassaye SG, Brown TT, Pomper MG, Coughlin JM, 2026 May AIDS 40

PET-Based Outcome Prediction in Patients with Prostate Cancer Scheduled for [225Ac]Ac-PSMA Radiopharmaceutical Therapy 

Widjaja L, Siegmund SC, Gildehaus FJ, Delker A, Schmidt-Hegemann NS, Pomper MG, Rowe SP, Bundschuh RA, Wenter V, Sheikh GT, Klimek K, Casuscelli J, Stief C, Zacherl MJ, Werner RA, 2026 Apr Journal of Nuclear Medicine 67 568-575

Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on 18F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest Cohort 

Islam MZ, Perk TG, Weisman A, Markowski MC, Pienta KJ, Whang YE, Milowsky MI, Pomper MG, Wisniewski N, Bundschuh RA, Werner RA, Gorin MA, Rowe SP, 2026 Mar Tomography 12

Predicting the progression of MCI and Alzheimer’s disease on structural brain integrity and other features with machine learning 

Author Collaboration AD, Mieling M, Yousuf M, Bunzeck N, Spicer K, Longmire CF, Mintzer J, Rojas YG, Sotelo V, Hu W, Jones F, Saklad A, Seshadri S, Boegel A, Hill SJ, Newhouse P, Long R, Long C, Williams A, Acree A, Brawman-Mintzer O, Reichert C, Pomara V, Hernando R, Pomara N, Acothley S, Elayan N, Slaughter ME, Garcia A, Sabbagh M, Gurung M, Le R, Masdeu J, Rosario C, Smith C, Kalowsky T, Rivera E, Okhravi H, Devine R, Yong M, Roglaski E, Janavs J, Echevarria J, Mba I, Smith A, Miller BL, Rosen HJ, Blackburn M, Kelley B, McColl R, Pomper M, 2026 Feb GeroScience 48 463-487

Artificial intelligence-based lesion characterization and outcome prediction of prostate cancer on [18F]DCFPyL PSMA imaging 

Zhao L, Imami MR, Wang Y, Mao Y, Hsu WC, Chen R, Mena E, Li Y, Tang J, Wu J, Voter AF, Amindarolzarbi A, Kargilis D, Afyouni S, Gafita A, Chen J, Chin BB, Leal JP, Du Y, Lin G, Jiao Z, Choyke PL, Rowe SP, Pomper MG, Liao W, Bai HX, 2026 Jan Radiotherapy and Oncology 214

Sex and APOE genotype specific brain regional vulnerability to Alzheimer's Disease 

Author Collaboration Mo, Zeng Q, Wang M, Wang E, Zhou X, Xu P, Haroutunian V, Cai D, Zhang B, Spicer K, Longmire CF, Mintzer J, Rojas YG, Sotelo V, Hu W, Jones F, Saklad A, Seshadri S, Boegel A, Hill SJ, Newhouse P, Long R, Long C, Williams A, Acree A, Brawman-Mintzer O, Reichert C, Pomara V, Hernando R, Pomara N, Acothley S, Elayan N, Slaughter ME, Garcia A, Sabbagh M, Gurung M, Le R, Masdeu J, Rosario C, Smith C, Kalowsky T, Rivera E, Okhravi H, Devine R, Yong M, Roglaski E, Kelley B, McColl R, Mathews D, Nguyen T, Pomper M, 2026 GeroScience

Applying multimodal dendrimers for prostate cancer theranostics 

Lesniak WG, Pomper MG, 2026 Nanomedicine 21 1179-1193